The HIV-prevention drug, PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.
Disparities in use of the pill are also geographic. Nearly half of all PrEP users reside in five states that account for 37 percent of the U.S. population — California, Florida, New York, Illinois and Texas — according to AIDSVu. The majority of new HIV diagnoses — 52 percent — are in the South.
For more, read Anna Gorman’s coverage.